Quadria Group-backed HealthQuad Backs LifeSigns to Scale AI-Powered Continuous Patient Monitoring

Hari Subramaniam, Founder and CEO, LifeSigns

• Partnership to strengthen LifeSigns’ integrated patient monitoring offering and accelerate company’s global expansion by leveraging HealthQuad’s global healthcare network

HealthQuad, the growth venture arm of Quadria Group focused on backing new-age healthcare models, has announced its latest investment in LifeSigns (www.lifesigns.us), India’s leading AI powered remote patient monitoring platform.

This underscores HealthQuad’s healthcare innovation led investment thesis. Healthcare must move from episodic and reactive care to continuous and predictive intelligence. . As health systems globally face rising demand in and beyond metros, workforce constraints, and cost pressures, the ability to monitor patients continuously and act early is becoming critical. LifeSigns is using AI to build a new layer of care that detects early signs of deterioration, enables timely clinical decisions, and ultimately saves lives.With deployment across tier 2 cities, an occupancy-based frugal pricing model and easy-to-scale solution, LifeSigns is driving access to high-quality healthcare where it is most needed.

For HealthQuad, this represents a high conviction investment in the next wave of healthcare innovation, where AI delivers measurable clinical impact at scale. As LifeSigns’ first institutional investor, HealthQuad brings more than just capital. Backed by Quadria’s global healthcare ecosystem, the partnership will focus on two key priorities for LifeSigns: international expansion across Southeast Asia and the GCC and strengthening its AI-led technology stack through selective integrations.

HealthQuad Fund III, a successor to HealthQuad Fund I and Fund II, aims to invest in category-defining companies of global relevance that are building bold, scalable solutions solving real-world problems.

Rahul Agarwal, Partner, HealthQuad

Rahul Agarwal, Partner, HealthQuad, said “Healthcare today is built on periodic observation while risk is real time. The future lies in continuous monitoring led predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built. With access to Quadria’s ecosystem, we are well positioned to help Hari and LifeSigns team to scale across global markets.”

Hari Subramaniam, Founder and CEO, LifeSigns, added “No patient should deteriorate silently because systems are not designed to continuously monitor them. That belief built LifeSigns. Our platform has demonstrated both clinical impact and scalability in India. With HealthQuad and Quadria, we now have the strategic depth to take this model global and make predictive care the standard.”

The global remote patient monitoring devices market stands at USD 26Bn in 2025 as health systems globally are shifting from episodic care toward continuous, decentralised monitoring.

LifeSigns has developed an integrated, US-FDA approved continuous monitoring platform that integrates a medical grade wearable, cloud dashboard, and predictive AI engine. It operates across the care continuum, from ambulances and emergency rooms to ICUs, wards, and home care.

The platform tracks key vitals including ECG, heart rate, respiration, temperature, blood pressure, and oxygen saturation. Its AI engine can detect early signs of deterioration up to 26 hours in advance and flag critical risk within a four-hour window, enabling timely intervention. Across more than 50 leading hospitals in India, LifeSigns has delivered over 87,000 life-saving alerts, reduced code blue incidents by nearly 90 percent, and lowered ICU readmissions by close to 78 percent. Its central monitoring command center enables scalable remote surveillance and helps address structural challenges.